These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23794039)

  • 1. Altered brain uptake of therapeutics in a triple transgenic mouse model of Alzheimer's disease.
    Mehta DC; Short JL; Nicolazzo JA
    Pharm Res; 2013 Nov; 30(11):2868-79. PubMed ID: 23794039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-Dependent Regulation of the Blood-Brain Barrier Influx/Efflux Equilibrium of Amyloid-β Peptide in a Mouse Model of Alzheimer's Disease (3xTg-AD).
    Do TM; Dodacki A; Alata W; Calon F; Nicolic S; Scherrmann JM; Farinotti R; Bourasset F
    J Alzheimers Dis; 2016; 49(2):287-300. PubMed ID: 26484906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered cerebral vascular volumes and solute transport at the blood-brain barriers of two transgenic mouse models of Alzheimer's disease.
    Do TM; Alata W; Dodacki A; Traversy MT; Chacun H; Pradier L; Scherrmann JM; Farinotti R; Calon F; Bourasset F
    Neuropharmacology; 2014 Jun; 81():311-7. PubMed ID: 24631967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal Permeability and Oral Absorption of Selected Drugs Are Reduced in a Mouse Model of Familial Alzheimer's Disease.
    Jin L; Pan Y; Tran NLL; Polychronopoulos LN; Warrier A; Brouwer KLR; Nicolazzo JA
    Mol Pharm; 2020 May; 17(5):1527-1537. PubMed ID: 32212738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal chemokine profile expression in a blood-brain barrier model from Alzheimer transgenic versus wild-type mice.
    Vérité J; Janet T; Chassaing D; Fauconneau B; Rabeony H; Page G
    J Neuroinflammation; 2018 Jun; 15(1):182. PubMed ID: 29898739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease.
    Bourasset F; Ouellet M; Tremblay C; Julien C; Do TM; Oddo S; LaFerla F; Calon F
    Neuropharmacology; 2009 Mar; 56(4):808-13. PubMed ID: 19705573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced CNS exposure of memantine in a triple transgenic mouse model of Alzheimer's disease assessed using a novel LC-MS technique.
    Mehta DC; Short JL; Nicolazzo JA
    J Pharm Biomed Anal; 2013 Nov; 85():198-206. PubMed ID: 23954439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stroke-induced opposite and age-dependent changes of vessel-associated markers in co-morbid transgenic mice with Alzheimer-like alterations.
    Hawkes CA; Michalski D; Anders R; Nissel S; Grosche J; Bechmann I; Carare RO; Härtig W
    Exp Neurol; 2013 Dec; 250():270-81. PubMed ID: 24103194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transport of cryptotanshinone, a major active triterpenoid in Salvia miltiorrhiza Bunge widely used in the treatment of stroke and Alzheimer's disease, across the blood-brain barrier.
    Yu XY; Lin SG; Chen X; Zhou ZW; Liang J; Duan W; Chowbay B; Wen JY; Chan E; Cao J; Li CG; Zhou SF
    Curr Drug Metab; 2007 May; 8(4):365-78. PubMed ID: 17504224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of nonpeptidic delta agonists with P-glycoprotein by in situ mouse brain perfusion: liquid chromatography-mass spectrometry analysis and internal standard strategy.
    Dagenais C; Ducharme J; Pollack GM
    J Pharm Sci; 2002 Jan; 91(1):244-52. PubMed ID: 11782913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultrasound with microbubbles improves memory, ameliorates pathology and modulates hippocampal proteomic changes in a triple transgenic mouse model of Alzheimer's disease.
    Shen Y; Hua L; Yeh CK; Shen L; Ying M; Zhang Z; Liu G; Li S; Chen S; Chen X; Yang X
    Theranostics; 2020; 10(25):11794-11819. PubMed ID: 33052247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol drinking exacerbates neural and behavioral pathology in the 3xTg-AD mouse model of Alzheimer's disease.
    Hoffman JL; Faccidomo S; Kim M; Taylor SM; Agoglia AE; May AM; Smith EN; Wong LC; Hodge CW
    Int Rev Neurobiol; 2019; 148():169-230. PubMed ID: 31733664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, up-regulation, and transport activity of the multidrug-resistance protein Abcg2 at the mouse blood-brain barrier.
    Cisternino S; Mercier C; Bourasset F; Roux F; Scherrmann JM
    Cancer Res; 2004 May; 64(9):3296-301. PubMed ID: 15126373
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intermittent Hypoxic Conditioning Rescues Cognition and Mitochondrial Bioenergetic Profile in the Triple Transgenic Mouse Model of Alzheimer's Disease.
    Correia SC; Machado NJ; Alves MG; Oliveira PF; Moreira PI
    Int J Mol Sci; 2021 Jan; 22(1):. PubMed ID: 33466445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of multidrug-resistance sensitive drugs by in situ brain perfusion in P-glycoprotein-deficient mice.
    Cisternino S; Rousselle C; Dagenais C; Scherrmann JM
    Pharm Res; 2001 Feb; 18(2):183-90. PubMed ID: 11405289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease and type 2 diabetes-related alterations in brain mitochondria, autophagy and synaptic markers.
    Carvalho C; Santos MS; Oliveira CR; Moreira PI
    Biochim Biophys Acta; 2015 Aug; 1852(8):1665-75. PubMed ID: 25960150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormal circadian locomotor rhythms and Per gene expression in six-month-old triple transgenic mice model of Alzheimer's disease.
    Wu M; Zhou F; Cao X; Yang J; Bai Y; Yan X; Cao J; Qi J
    Neurosci Lett; 2018 May; 676():13-18. PubMed ID: 29626648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ transport of vinblastine and selected P-glycoprotein substrates: implications for drug-drug interactions at the mouse blood-brain barrier.
    Cisternino S; Rousselle C; Debray M; Scherrmann JM
    Pharm Res; 2004 Aug; 21(8):1382-9. PubMed ID: 15359572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial bioenergetic deficit precedes Alzheimer's pathology in female mouse model of Alzheimer's disease.
    Yao J; Irwin RW; Zhao L; Nilsen J; Hamilton RT; Brinton RD
    Proc Natl Acad Sci U S A; 2009 Aug; 106(34):14670-5. PubMed ID: 19667196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic alterations induced by sucrose intake and Alzheimer's disease promote similar brain mitochondrial abnormalities.
    Carvalho C; Cardoso S; Correia SC; Santos RX; Santos MS; Baldeiras I; Oliveira CR; Moreira PI
    Diabetes; 2012 May; 61(5):1234-42. PubMed ID: 22427376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.